Legend Biotech (LEGN) reported a Q1 adjusted net loss Tuesday of $0.07 per share, narrowing from a loss of $0.23 a year earlier.
One analyst surveyed by FactSet expected a loss of $0.21 per share.
Revenue for the quarter ended March 31 was $195.1 million, up from $94 million a year earlier.
Analysts surveyed by FactSet expected $193.6 million.
Shares of the company were up more than 1.9% in recent Tuesday premarket activity.
Price: 33.00, Change: +0.62, Percent Change: +1.91
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。